nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—Glyburide—type 2 diabetes mellitus	0.287	1	CrCtD
Bezafibrate—HMGCR—type 2 diabetes mellitus	0.0749	0.376	CbGaD
Bezafibrate—PPARA—type 2 diabetes mellitus	0.0737	0.37	CbGaD
Bezafibrate—Glyburide—Tolazamide—type 2 diabetes mellitus	0.0395	0.21	CrCrCtD
Bezafibrate—Glyburide—Glimepiride—type 2 diabetes mellitus	0.0395	0.21	CrCrCtD
Bezafibrate—Glyburide—Gliclazide—type 2 diabetes mellitus	0.0375	0.199	CrCrCtD
Bezafibrate—Glyburide—Glipizide—type 2 diabetes mellitus	0.0375	0.199	CrCrCtD
Bezafibrate—PPARG—type 2 diabetes mellitus	0.0353	0.177	CbGaD
Bezafibrate—PPARG—Glipizide—type 2 diabetes mellitus	0.0348	0.157	CbGbCtD
Bezafibrate—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.0343	0.182	CrCrCtD
Bezafibrate—PPARG—Repaglinide—type 2 diabetes mellitus	0.0305	0.137	CbGbCtD
Bezafibrate—PPARG—Pioglitazone—type 2 diabetes mellitus	0.0275	0.124	CbGbCtD
Bezafibrate—PPARG—Rosiglitazone—type 2 diabetes mellitus	0.0254	0.114	CbGbCtD
Bezafibrate—PPARG—Nateglinide—type 2 diabetes mellitus	0.0209	0.0938	CbGbCtD
Bezafibrate—CYP3A4—type 2 diabetes mellitus	0.0152	0.0764	CbGaD
Bezafibrate—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0105	0.047	CbGbCtD
Bezafibrate—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.00947	0.0425	CbGbCtD
Bezafibrate—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.00874	0.0393	CbGbCtD
Bezafibrate—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.00772	0.0347	CbGbCtD
Bezafibrate—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00554	0.0249	CbGbCtD
Bezafibrate—SLCO1B1—Losartan—type 2 diabetes mellitus	0.00443	0.0199	CbGbCtD
Bezafibrate—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00443	0.0199	CbGbCtD
Bezafibrate—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00401	0.018	CbGbCtD
Bezafibrate—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0037	0.0166	CbGbCtD
Bezafibrate—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00357	0.016	CbGbCtD
Bezafibrate—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00291	0.0131	CbGbCtD
Bezafibrate—PPARA—brown adipose tissue—type 2 diabetes mellitus	0.00254	0.164	CbGeAlD
Bezafibrate—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00252	0.0113	CbGbCtD
Bezafibrate—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00225	0.0101	CbGbCtD
Bezafibrate—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00206	0.00924	CbGbCtD
Bezafibrate—CYP2C8—Losartan—type 2 diabetes mellitus	0.00188	0.00843	CbGbCtD
Bezafibrate—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0018	0.00807	CbGbCtD
Bezafibrate—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00162	0.0073	CbGbCtD
Bezafibrate—PPARG—brown adipose tissue—type 2 diabetes mellitus	0.0014	0.0899	CbGeAlD
Bezafibrate—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00123	0.00553	CbGbCtD
Bezafibrate—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00118	0.0053	CbGbCtD
Bezafibrate—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00118	0.0053	CbGbCtD
Bezafibrate—PPARG—leg—type 2 diabetes mellitus	0.00112	0.0723	CbGeAlD
Bezafibrate—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00112	0.00502	CbGbCtD
Bezafibrate—PPARG—hindlimb—type 2 diabetes mellitus	0.001	0.0646	CbGeAlD
Bezafibrate—CYP3A4—Glyburide—type 2 diabetes mellitus	0.000832	0.00374	CbGbCtD
Bezafibrate—CYP3A4—Losartan—type 2 diabetes mellitus	0.000761	0.00342	CbGbCtD
Bezafibrate—PPARD—islet of Langerhans—type 2 diabetes mellitus	0.00063	0.0406	CbGeAlD
Bezafibrate—PPARG—artery—type 2 diabetes mellitus	0.000615	0.0396	CbGeAlD
Bezafibrate—PPARG—endothelium—type 2 diabetes mellitus	0.000519	0.0335	CbGeAlD
Bezafibrate—PPARA—retina—type 2 diabetes mellitus	0.000459	0.0296	CbGeAlD
Bezafibrate—PPARD—pancreas—type 2 diabetes mellitus	0.000443	0.0285	CbGeAlD
Bezafibrate—PPARD—adipose tissue—type 2 diabetes mellitus	0.000402	0.0259	CbGeAlD
Bezafibrate—PPARA—cardiovascular system—type 2 diabetes mellitus	0.000388	0.025	CbGeAlD
Bezafibrate—PPARA—kidney—type 2 diabetes mellitus	0.00038	0.0245	CbGeAlD
Bezafibrate—PPARA—pancreas—type 2 diabetes mellitus	0.000378	0.0243	CbGeAlD
Bezafibrate—HMGCR—islet of Langerhans—type 2 diabetes mellitus	0.000357	0.023	CbGeAlD
Bezafibrate—PPARA—adipose tissue—type 2 diabetes mellitus	0.000343	0.0221	CbGeAlD
Bezafibrate—PPARG—islet of Langerhans—type 2 diabetes mellitus	0.000295	0.019	CbGeAlD
Bezafibrate—HMGCR—nephron tubule—type 2 diabetes mellitus	0.000288	0.0185	CbGeAlD
Bezafibrate—PPARD—liver—type 2 diabetes mellitus	0.000282	0.0182	CbGeAlD
Bezafibrate—Fenofibrate—PPARA—type 2 diabetes mellitus	0.00027	0.174	CrCbGaD
Bezafibrate—HMGCR—cardiovascular system—type 2 diabetes mellitus	0.000259	0.0167	CbGeAlD
Bezafibrate—HMGCR—kidney—type 2 diabetes mellitus	0.000253	0.0163	CbGeAlD
Bezafibrate—HMGCR—pancreas—type 2 diabetes mellitus	0.000251	0.0162	CbGeAlD
Bezafibrate—HMGCR—cortex of kidney—type 2 diabetes mellitus	0.000246	0.0159	CbGeAlD
Bezafibrate—SLCO1B1—kidney—type 2 diabetes mellitus	0.000242	0.0156	CbGeAlD
Bezafibrate—PPARA—liver—type 2 diabetes mellitus	0.00024	0.0155	CbGeAlD
Bezafibrate—HMGCR—adipose tissue—type 2 diabetes mellitus	0.000228	0.0147	CbGeAlD
Bezafibrate—PPARG—cardiovascular system—type 2 diabetes mellitus	0.000214	0.0138	CbGeAlD
Bezafibrate—PPARG—kidney—type 2 diabetes mellitus	0.000209	0.0135	CbGeAlD
Bezafibrate—PPARG—pancreas—type 2 diabetes mellitus	0.000208	0.0134	CbGeAlD
Bezafibrate—PPARG—adipose tissue—type 2 diabetes mellitus	0.000188	0.0121	CbGeAlD
Bezafibrate—Clofibrate—PPARA—type 2 diabetes mellitus	0.000187	0.121	CrCbGaD
Bezafibrate—Glyburide—CPT1A—type 2 diabetes mellitus	0.000161	0.104	CrCbGaD
Bezafibrate—HMGCR—liver—type 2 diabetes mellitus	0.00016	0.0103	CbGeAlD
Bezafibrate—SLCO1B1—liver—type 2 diabetes mellitus	0.000153	0.00987	CbGeAlD
Bezafibrate—CYP2C8—kidney—type 2 diabetes mellitus	0.000138	0.00888	CbGeAlD
Bezafibrate—PPARG—liver—type 2 diabetes mellitus	0.000132	0.00851	CbGeAlD
Bezafibrate—CYP1A1—kidney—type 2 diabetes mellitus	0.000127	0.00819	CbGeAlD
Bezafibrate—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000115	0.00739	CbGeAlD
Bezafibrate—Glyburide—ABCC8—type 2 diabetes mellitus	0.000112	0.0722	CrCbGaD
Bezafibrate—Balsalazide—PPARG—type 2 diabetes mellitus	0.00011	0.0708	CrCbGaD
Bezafibrate—Indomethacin—PPARA—type 2 diabetes mellitus	0.000101	0.0652	CrCbGaD
Bezafibrate—CYP3A4—kidney—type 2 diabetes mellitus	9.33e-05	0.00601	CbGeAlD
Bezafibrate—CYP2C8—liver—type 2 diabetes mellitus	8.71e-05	0.00561	CbGeAlD
Bezafibrate—CYP1A1—liver—type 2 diabetes mellitus	8.04e-05	0.00518	CbGeAlD
Bezafibrate—Glyburide—KCNJ11—type 2 diabetes mellitus	7.89e-05	0.0509	CrCbGaD
Bezafibrate—Myocardial infarction—Irbesartan—type 2 diabetes mellitus	7.61e-05	0.00169	CcSEcCtD
Bezafibrate—Infection—Bromocriptine—type 2 diabetes mellitus	7.59e-05	0.00169	CcSEcCtD
Bezafibrate—Flatulence—Gliclazide—type 2 diabetes mellitus	7.57e-05	0.00169	CcSEcCtD
Bezafibrate—Erectile dysfunction—Losartan—type 2 diabetes mellitus	7.54e-05	0.00168	CcSEcCtD
Bezafibrate—Nausea—Nateglinide—type 2 diabetes mellitus	7.52e-05	0.00168	CcSEcCtD
Bezafibrate—Liver function test abnormal—Ramipril—type 2 diabetes mellitus	7.5e-05	0.00167	CcSEcCtD
Bezafibrate—Diarrhoea—Repaglinide—type 2 diabetes mellitus	7.5e-05	0.00167	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	7.48e-05	0.00166	CcSEcCtD
Bezafibrate—Dyspepsia—Glimepiride—type 2 diabetes mellitus	7.45e-05	0.00166	CcSEcCtD
Bezafibrate—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	7.43e-05	0.00165	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	7.42e-05	0.00165	CcSEcCtD
Bezafibrate—Pruritus—Rosiglitazone—type 2 diabetes mellitus	7.33e-05	0.00163	CcSEcCtD
Bezafibrate—Cramp muscle—Ramipril—type 2 diabetes mellitus	7.32e-05	0.00163	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	7.32e-05	0.00163	CcSEcCtD
Bezafibrate—Myalgia—Glyburide—type 2 diabetes mellitus	7.28e-05	0.00162	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	7.24e-05	0.00161	CcSEcCtD
Bezafibrate—Pain—Sitagliptin—type 2 diabetes mellitus	7.22e-05	0.00161	CcSEcCtD
Bezafibrate—Constipation—Sitagliptin—type 2 diabetes mellitus	7.22e-05	0.00161	CcSEcCtD
Bezafibrate—Urticaria—Glipizide—type 2 diabetes mellitus	7.21e-05	0.0016	CcSEcCtD
Bezafibrate—Gastritis—Ramipril—type 2 diabetes mellitus	7.19e-05	0.0016	CcSEcCtD
Bezafibrate—Abdominal pain—Glipizide—type 2 diabetes mellitus	7.17e-05	0.0016	CcSEcCtD
Bezafibrate—Alopecia—Valsartan—type 2 diabetes mellitus	7.16e-05	0.0016	CcSEcCtD
Bezafibrate—Anaemia—Gliclazide—type 2 diabetes mellitus	7.1e-05	0.00158	CcSEcCtD
Bezafibrate—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	7.09e-05	0.00158	CcSEcCtD
Bezafibrate—Alopecia—Orlistat—type 2 diabetes mellitus	7.08e-05	0.00158	CcSEcCtD
Bezafibrate—Influenza—Ramipril—type 2 diabetes mellitus	7.02e-05	0.00156	CcSEcCtD
Bezafibrate—Flatulence—Valsartan—type 2 diabetes mellitus	6.95e-05	0.00155	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	6.92e-05	0.00154	CcSEcCtD
Bezafibrate—Pharyngitis—Irbesartan—type 2 diabetes mellitus	6.91e-05	0.00154	CcSEcCtD
Bezafibrate—Rash—Repaglinide—type 2 diabetes mellitus	6.91e-05	0.00154	CcSEcCtD
Bezafibrate—Insomnia—Bromocriptine—type 2 diabetes mellitus	6.91e-05	0.00154	CcSEcCtD
Bezafibrate—Dermatitis—Repaglinide—type 2 diabetes mellitus	6.91e-05	0.00154	CcSEcCtD
Bezafibrate—Urticaria—Pioglitazone—type 2 diabetes mellitus	6.9e-05	0.00154	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	6.9e-05	0.00154	CcSEcCtD
Bezafibrate—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	6.88e-05	0.00153	CcSEcCtD
Bezafibrate—Flatulence—Orlistat—type 2 diabetes mellitus	6.87e-05	0.00153	CcSEcCtD
Bezafibrate—Headache—Repaglinide—type 2 diabetes mellitus	6.87e-05	0.00153	CcSEcCtD
Bezafibrate—Dizziness—Rosiglitazone—type 2 diabetes mellitus	6.85e-05	0.00153	CcSEcCtD
Bezafibrate—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	6.84e-05	0.00152	CcSEcCtD
Bezafibrate—Urethral disorder—Irbesartan—type 2 diabetes mellitus	6.83e-05	0.00152	CcSEcCtD
Bezafibrate—Muscle spasms—Valsartan—type 2 diabetes mellitus	6.78e-05	0.00151	CcSEcCtD
Bezafibrate—Bronchitis—Ramipril—type 2 diabetes mellitus	6.75e-05	0.0015	CcSEcCtD
Bezafibrate—Urticaria—Glimepiride—type 2 diabetes mellitus	6.73e-05	0.0015	CcSEcCtD
Bezafibrate—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	6.72e-05	0.0015	CcSEcCtD
Bezafibrate—Muscle spasms—Orlistat—type 2 diabetes mellitus	6.7e-05	0.00149	CcSEcCtD
Bezafibrate—Urticaria—Sitagliptin—type 2 diabetes mellitus	6.7e-05	0.00149	CcSEcCtD
Bezafibrate—Abdominal pain—Glimepiride—type 2 diabetes mellitus	6.69e-05	0.00149	CcSEcCtD
Bezafibrate—Hypersensitivity—Glipizide—type 2 diabetes mellitus	6.68e-05	0.00149	CcSEcCtD
Bezafibrate—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	6.67e-05	0.00149	CcSEcCtD
Bezafibrate—Pancytopenia—Ramipril—type 2 diabetes mellitus	6.67e-05	0.00149	CcSEcCtD
Bezafibrate—Moclobemide—CYP1A2—type 2 diabetes mellitus	6.54e-05	0.0422	CrCbGaD
Bezafibrate—Myalgia—Gliclazide—type 2 diabetes mellitus	6.54e-05	0.00146	CcSEcCtD
Bezafibrate—Rash—Rosiglitazone—type 2 diabetes mellitus	6.53e-05	0.00145	CcSEcCtD
Bezafibrate—Constipation—Bromocriptine—type 2 diabetes mellitus	6.53e-05	0.00145	CcSEcCtD
Bezafibrate—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	6.53e-05	0.00145	CcSEcCtD
Bezafibrate—Nausea—Repaglinide—type 2 diabetes mellitus	6.51e-05	0.00145	CcSEcCtD
Bezafibrate—Pharyngitis—Losartan—type 2 diabetes mellitus	6.51e-05	0.00145	CcSEcCtD
Bezafibrate—Headache—Rosiglitazone—type 2 diabetes mellitus	6.49e-05	0.00145	CcSEcCtD
Bezafibrate—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	6.47e-05	0.00144	CcSEcCtD
Bezafibrate—Erythema—Metformin—type 2 diabetes mellitus	6.43e-05	0.00143	CcSEcCtD
Bezafibrate—Pruritus—Glipizide—type 2 diabetes mellitus	6.42e-05	0.00143	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	6.41e-05	0.00143	CcSEcCtD
Bezafibrate—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	6.4e-05	0.00143	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	6.36e-05	0.00142	CcSEcCtD
Bezafibrate—Flatulence—Metformin—type 2 diabetes mellitus	6.33e-05	0.00141	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	6.24e-05	0.00139	CcSEcCtD
Bezafibrate—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	6.24e-05	0.00139	CcSEcCtD
Bezafibrate—Infection—Gliclazide—type 2 diabetes mellitus	6.23e-05	0.00139	CcSEcCtD
Bezafibrate—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	6.22e-05	0.00138	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	6.21e-05	0.00138	CcSEcCtD
Bezafibrate—Diarrhoea—Glipizide—type 2 diabetes mellitus	6.21e-05	0.00138	CcSEcCtD
Bezafibrate—Erythema multiforme—Losartan—type 2 diabetes mellitus	6.2e-05	0.00138	CcSEcCtD
Bezafibrate—Muscle spasms—Metformin—type 2 diabetes mellitus	6.18e-05	0.00138	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	6.17e-05	0.00137	CcSEcCtD
Bezafibrate—Nausea—Rosiglitazone—type 2 diabetes mellitus	6.16e-05	0.00137	CcSEcCtD
Bezafibrate—Dyspepsia—Glyburide—type 2 diabetes mellitus	6.15e-05	0.00137	CcSEcCtD
Bezafibrate—Myocardial infarction—Ramipril—type 2 diabetes mellitus	6.14e-05	0.00137	CcSEcCtD
Bezafibrate—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	6.14e-05	0.00137	CcSEcCtD
Bezafibrate—Clofibrate—CYP2E1—type 2 diabetes mellitus	6.13e-05	0.0395	CrCbGaD
Bezafibrate—Urticaria—Bromocriptine—type 2 diabetes mellitus	6.07e-05	0.00135	CcSEcCtD
Bezafibrate—Erythema—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.00135	CcSEcCtD
Bezafibrate—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	6.04e-05	0.00134	CcSEcCtD
Bezafibrate—Myalgia—Valsartan—type 2 diabetes mellitus	6.01e-05	0.00134	CcSEcCtD
Bezafibrate—Dizziness—Glipizide—type 2 diabetes mellitus	6e-05	0.00134	CcSEcCtD
Bezafibrate—Pruritus—Glimepiride—type 2 diabetes mellitus	5.99e-05	0.00133	CcSEcCtD
Bezafibrate—Flatulence—Irbesartan—type 2 diabetes mellitus	5.98e-05	0.00133	CcSEcCtD
Bezafibrate—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	5.95e-05	0.00132	CcSEcCtD
Bezafibrate—Myalgia—Orlistat—type 2 diabetes mellitus	5.94e-05	0.00132	CcSEcCtD
Bezafibrate—CYP3A4—liver—type 2 diabetes mellitus	5.9e-05	0.0038	CbGeAlD
Bezafibrate—Muscle spasms—Irbesartan—type 2 diabetes mellitus	5.83e-05	0.0013	CcSEcCtD
Bezafibrate—Alopecia—Losartan—type 2 diabetes mellitus	5.79e-05	0.00129	CcSEcCtD
Bezafibrate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	5.79e-05	0.00129	CcSEcCtD
Bezafibrate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	5.77e-05	0.00129	CcSEcCtD
Bezafibrate—Dizziness—Pioglitazone—type 2 diabetes mellitus	5.75e-05	0.00128	CcSEcCtD
Bezafibrate—Infection—Valsartan—type 2 diabetes mellitus	5.72e-05	0.00127	CcSEcCtD
Bezafibrate—Rash—Glipizide—type 2 diabetes mellitus	5.72e-05	0.00127	CcSEcCtD
Bezafibrate—Dermatitis—Glipizide—type 2 diabetes mellitus	5.71e-05	0.00127	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	5.71e-05	0.00127	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	5.71e-05	0.00127	CcSEcCtD
Bezafibrate—Erythema—Losartan—type 2 diabetes mellitus	5.71e-05	0.00127	CcSEcCtD
Bezafibrate—Headache—Glipizide—type 2 diabetes mellitus	5.68e-05	0.00127	CcSEcCtD
Bezafibrate—Insomnia—Gliclazide—type 2 diabetes mellitus	5.67e-05	0.00126	CcSEcCtD
Bezafibrate—Infection—Orlistat—type 2 diabetes mellitus	5.65e-05	0.00126	CcSEcCtD
Bezafibrate—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	5.64e-05	0.00126	CcSEcCtD
Bezafibrate—Flatulence—Losartan—type 2 diabetes mellitus	5.62e-05	0.00125	CcSEcCtD
Bezafibrate—Anaemia—Irbesartan—type 2 diabetes mellitus	5.61e-05	0.00125	CcSEcCtD
Bezafibrate—Dizziness—Glimepiride—type 2 diabetes mellitus	5.6e-05	0.00125	CcSEcCtD
Bezafibrate—Dizziness—Sitagliptin—type 2 diabetes mellitus	5.58e-05	0.00124	CcSEcCtD
Bezafibrate—Fenofibrate—CYP3A4—type 2 diabetes mellitus	5.57e-05	0.0359	CrCbGaD
Bezafibrate—Urticaria—Glyburide—type 2 diabetes mellitus	5.55e-05	0.00123	CcSEcCtD
Bezafibrate—Abdominal pain—Glyburide—type 2 diabetes mellitus	5.52e-05	0.00123	CcSEcCtD
Bezafibrate—Dyspepsia—Gliclazide—type 2 diabetes mellitus	5.52e-05	0.00123	CcSEcCtD
Bezafibrate—Muscle spasms—Losartan—type 2 diabetes mellitus	5.49e-05	0.00122	CcSEcCtD
Bezafibrate—Myalgia—Metformin—type 2 diabetes mellitus	5.47e-05	0.00122	CcSEcCtD
Bezafibrate—Headache—Pioglitazone—type 2 diabetes mellitus	5.44e-05	0.00121	CcSEcCtD
Bezafibrate—Nausea—Glipizide—type 2 diabetes mellitus	5.39e-05	0.0012	CcSEcCtD
Bezafibrate—Pain—Gliclazide—type 2 diabetes mellitus	5.36e-05	0.00119	CcSEcCtD
Bezafibrate—Constipation—Gliclazide—type 2 diabetes mellitus	5.36e-05	0.00119	CcSEcCtD
Bezafibrate—Rash—Glimepiride—type 2 diabetes mellitus	5.34e-05	0.00119	CcSEcCtD
Bezafibrate—Dermatitis—Glimepiride—type 2 diabetes mellitus	5.33e-05	0.00119	CcSEcCtD
Bezafibrate—Rash—Sitagliptin—type 2 diabetes mellitus	5.32e-05	0.00118	CcSEcCtD
Bezafibrate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	5.32e-05	0.00118	CcSEcCtD
Bezafibrate—Erythema multiforme—Ramipril—type 2 diabetes mellitus	5.32e-05	0.00118	CcSEcCtD
Bezafibrate—Headache—Glimepiride—type 2 diabetes mellitus	5.3e-05	0.00118	CcSEcCtD
Bezafibrate—Headache—Sitagliptin—type 2 diabetes mellitus	5.29e-05	0.00118	CcSEcCtD
Bezafibrate—Anaemia—Losartan—type 2 diabetes mellitus	5.28e-05	0.00117	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	5.25e-05	0.00117	CcSEcCtD
Bezafibrate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.23e-05	0.00116	CcSEcCtD
Bezafibrate—Infection—Metformin—type 2 diabetes mellitus	5.21e-05	0.00116	CcSEcCtD
Bezafibrate—Insomnia—Valsartan—type 2 diabetes mellitus	5.21e-05	0.00116	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	5.19e-05	0.00115	CcSEcCtD
Bezafibrate—Myalgia—Irbesartan—type 2 diabetes mellitus	5.16e-05	0.00115	CcSEcCtD
Bezafibrate—Insomnia—Orlistat—type 2 diabetes mellitus	5.15e-05	0.00115	CcSEcCtD
Bezafibrate—Aminohippurate—ABCC2—type 2 diabetes mellitus	5.15e-05	0.0332	CrCbGaD
Bezafibrate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.14e-05	0.00115	CcSEcCtD
Bezafibrate—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.14e-05	0.00114	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.13e-05	0.00114	CcSEcCtD
Bezafibrate—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.07e-05	0.00113	CcSEcCtD
Bezafibrate—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.05e-05	0.00112	CcSEcCtD
Bezafibrate—Nausea—Glimepiride—type 2 diabetes mellitus	5.03e-05	0.00112	CcSEcCtD
Bezafibrate—Nausea—Sitagliptin—type 2 diabetes mellitus	5.01e-05	0.00112	CcSEcCtD
Bezafibrate—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.01e-05	0.00112	CcSEcCtD
Bezafibrate—Urticaria—Gliclazide—type 2 diabetes mellitus	4.98e-05	0.00111	CcSEcCtD
Bezafibrate—Alopecia—Ramipril—type 2 diabetes mellitus	4.97e-05	0.00111	CcSEcCtD
Bezafibrate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.96e-05	0.0011	CcSEcCtD
Bezafibrate—Pruritus—Glyburide—type 2 diabetes mellitus	4.94e-05	0.0011	CcSEcCtD
Bezafibrate—Constipation—Valsartan—type 2 diabetes mellitus	4.93e-05	0.0011	CcSEcCtD
Bezafibrate—Infection—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.00109	CcSEcCtD
Bezafibrate—Erythema—Ramipril—type 2 diabetes mellitus	4.89e-05	0.00109	CcSEcCtD
Bezafibrate—Pain—Orlistat—type 2 diabetes mellitus	4.87e-05	0.00108	CcSEcCtD
Bezafibrate—Myalgia—Losartan—type 2 diabetes mellitus	4.86e-05	0.00108	CcSEcCtD
Bezafibrate—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.00108	CcSEcCtD
Bezafibrate—Indomethacin—PPARG—type 2 diabetes mellitus	4.84e-05	0.0312	CrCbGaD
Bezafibrate—Rash—Bromocriptine—type 2 diabetes mellitus	4.82e-05	0.00107	CcSEcCtD
Bezafibrate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.81e-05	0.00107	CcSEcCtD
Bezafibrate—Headache—Bromocriptine—type 2 diabetes mellitus	4.78e-05	0.00107	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.78e-05	0.00106	CcSEcCtD
Bezafibrate—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.78e-05	0.00106	CcSEcCtD
Bezafibrate—Indomethacin—ABCC2—type 2 diabetes mellitus	4.72e-05	0.0305	CrCbGaD
Bezafibrate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.71e-05	0.00105	CcSEcCtD
Bezafibrate—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.71e-05	0.00105	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.65e-05	0.00104	CcSEcCtD
Bezafibrate—Balsalazide—PTGS2—type 2 diabetes mellitus	4.63e-05	0.0299	CrCbGaD
Bezafibrate—Infection—Losartan—type 2 diabetes mellitus	4.63e-05	0.00103	CcSEcCtD
Bezafibrate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.62e-05	0.00103	CcSEcCtD
Bezafibrate—Dyspepsia—Metformin—type 2 diabetes mellitus	4.62e-05	0.00103	CcSEcCtD
Bezafibrate—Urticaria—Valsartan—type 2 diabetes mellitus	4.58e-05	0.00102	CcSEcCtD
Bezafibrate—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.56e-05	0.00102	CcSEcCtD
Bezafibrate—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.55e-05	0.00101	CcSEcCtD
Bezafibrate—Nausea—Bromocriptine—type 2 diabetes mellitus	4.54e-05	0.00101	CcSEcCtD
Bezafibrate—Urticaria—Orlistat—type 2 diabetes mellitus	4.52e-05	0.00101	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.51e-05	0.001	CcSEcCtD
Bezafibrate—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.5e-05	0.001	CcSEcCtD
Bezafibrate—Constipation—Metformin—type 2 diabetes mellitus	4.49e-05	0.000999	CcSEcCtD
Bezafibrate—Pruritus—Gliclazide—type 2 diabetes mellitus	4.44e-05	0.000988	CcSEcCtD
Bezafibrate—Rash—Glyburide—type 2 diabetes mellitus	4.4e-05	0.00098	CcSEcCtD
Bezafibrate—Dermatitis—Glyburide—type 2 diabetes mellitus	4.4e-05	0.000979	CcSEcCtD
Bezafibrate—Headache—Glyburide—type 2 diabetes mellitus	4.37e-05	0.000974	CcSEcCtD
Bezafibrate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.00097	CcSEcCtD
Bezafibrate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.29e-05	0.000955	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.29e-05	0.000955	CcSEcCtD
Bezafibrate—Glyburide—ABCC2—type 2 diabetes mellitus	4.26e-05	0.0275	CrCbGaD
Bezafibrate—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.24e-05	0.000945	CcSEcCtD
Bezafibrate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.24e-05	0.000945	CcSEcCtD
Bezafibrate—Pain—Irbesartan—type 2 diabetes mellitus	4.23e-05	0.000943	CcSEcCtD
Bezafibrate—Constipation—Irbesartan—type 2 diabetes mellitus	4.23e-05	0.000943	CcSEcCtD
Bezafibrate—Insomnia—Losartan—type 2 diabetes mellitus	4.21e-05	0.000938	CcSEcCtD
Bezafibrate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.19e-05	0.000934	CcSEcCtD
Bezafibrate—Urticaria—Metformin—type 2 diabetes mellitus	4.17e-05	0.000928	CcSEcCtD
Bezafibrate—Myalgia—Ramipril—type 2 diabetes mellitus	4.17e-05	0.000928	CcSEcCtD
Bezafibrate—Nausea—Glyburide—type 2 diabetes mellitus	4.15e-05	0.000923	CcSEcCtD
Bezafibrate—Abdominal pain—Metformin—type 2 diabetes mellitus	4.15e-05	0.000923	CcSEcCtD
Bezafibrate—Dizziness—Gliclazide—type 2 diabetes mellitus	4.15e-05	0.000923	CcSEcCtD
Bezafibrate—Dyspepsia—Losartan—type 2 diabetes mellitus	4.1e-05	0.000913	CcSEcCtD
Bezafibrate—Pruritus—Valsartan—type 2 diabetes mellitus	4.07e-05	0.000907	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.05e-05	0.000901	CcSEcCtD
Bezafibrate—Pruritus—Orlistat—type 2 diabetes mellitus	4.03e-05	0.000897	CcSEcCtD
Bezafibrate—Pain—Losartan—type 2 diabetes mellitus	3.98e-05	0.000887	CcSEcCtD
Bezafibrate—Constipation—Losartan—type 2 diabetes mellitus	3.98e-05	0.000887	CcSEcCtD
Bezafibrate—Rash—Gliclazide—type 2 diabetes mellitus	3.95e-05	0.00088	CcSEcCtD
Bezafibrate—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.95e-05	0.000879	CcSEcCtD
Bezafibrate—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.94e-05	0.000878	CcSEcCtD
Bezafibrate—Urticaria—Irbesartan—type 2 diabetes mellitus	3.93e-05	0.000876	CcSEcCtD
Bezafibrate—Headache—Gliclazide—type 2 diabetes mellitus	3.93e-05	0.000874	CcSEcCtD
Bezafibrate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.91e-05	0.000871	CcSEcCtD
Bezafibrate—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000871	CcSEcCtD
Bezafibrate—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.89e-05	0.000867	CcSEcCtD
Bezafibrate—Clofibrate—CYP3A4—type 2 diabetes mellitus	3.86e-05	0.0249	CrCbGaD
Bezafibrate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.81e-05	0.000848	CcSEcCtD
Bezafibrate—Dizziness—Valsartan—type 2 diabetes mellitus	3.81e-05	0.000848	CcSEcCtD
Bezafibrate—Dizziness—Orlistat—type 2 diabetes mellitus	3.76e-05	0.000838	CcSEcCtD
Bezafibrate—Nausea—Gliclazide—type 2 diabetes mellitus	3.72e-05	0.000829	CcSEcCtD
Bezafibrate—Pruritus—Metformin—type 2 diabetes mellitus	3.71e-05	0.000826	CcSEcCtD
Bezafibrate—Urticaria—Losartan—type 2 diabetes mellitus	3.7e-05	0.000824	CcSEcCtD
Bezafibrate—Abdominal pain—Losartan—type 2 diabetes mellitus	3.68e-05	0.00082	CcSEcCtD
Bezafibrate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.65e-05	0.000812	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.64e-05	0.00081	CcSEcCtD
Bezafibrate—Rash—Valsartan—type 2 diabetes mellitus	3.63e-05	0.000809	CcSEcCtD
Bezafibrate—Dermatitis—Valsartan—type 2 diabetes mellitus	3.63e-05	0.000808	CcSEcCtD
Bezafibrate—Insomnia—Ramipril—type 2 diabetes mellitus	3.61e-05	0.000804	CcSEcCtD
Bezafibrate—Headache—Valsartan—type 2 diabetes mellitus	3.61e-05	0.000803	CcSEcCtD
Bezafibrate—Diarrhoea—Metformin—type 2 diabetes mellitus	3.59e-05	0.000799	CcSEcCtD
Bezafibrate—Rash—Orlistat—type 2 diabetes mellitus	3.59e-05	0.000799	CcSEcCtD
Bezafibrate—Dermatitis—Orlistat—type 2 diabetes mellitus	3.59e-05	0.000798	CcSEcCtD
Bezafibrate—Headache—Orlistat—type 2 diabetes mellitus	3.57e-05	0.000794	CcSEcCtD
Bezafibrate—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000783	CcSEcCtD
Bezafibrate—Pruritus—Irbesartan—type 2 diabetes mellitus	3.5e-05	0.00078	CcSEcCtD
Bezafibrate—Dizziness—Metformin—type 2 diabetes mellitus	3.47e-05	0.000772	CcSEcCtD
Bezafibrate—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.43e-05	0.000764	CcSEcCtD
Bezafibrate—Nausea—Valsartan—type 2 diabetes mellitus	3.42e-05	0.000762	CcSEcCtD
Bezafibrate—Constipation—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000761	CcSEcCtD
Bezafibrate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.39e-05	0.000754	CcSEcCtD
Bezafibrate—Nausea—Orlistat—type 2 diabetes mellitus	3.38e-05	0.000753	CcSEcCtD
Bezafibrate—Rash—Metformin—type 2 diabetes mellitus	3.31e-05	0.000736	CcSEcCtD
Bezafibrate—Dermatitis—Metformin—type 2 diabetes mellitus	3.3e-05	0.000736	CcSEcCtD
Bezafibrate—Pruritus—Losartan—type 2 diabetes mellitus	3.3e-05	0.000734	CcSEcCtD
Bezafibrate—Headache—Metformin—type 2 diabetes mellitus	3.29e-05	0.000732	CcSEcCtD
Bezafibrate—Dizziness—Irbesartan—type 2 diabetes mellitus	3.27e-05	0.000729	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000727	CcSEcCtD
Bezafibrate—Diarrhoea—Losartan—type 2 diabetes mellitus	3.19e-05	0.00071	CcSEcCtD
Bezafibrate—Urticaria—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000707	CcSEcCtD
Bezafibrate—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000703	CcSEcCtD
Bezafibrate—Rash—Irbesartan—type 2 diabetes mellitus	3.12e-05	0.000695	CcSEcCtD
Bezafibrate—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.12e-05	0.000694	CcSEcCtD
Bezafibrate—Nausea—Metformin—type 2 diabetes mellitus	3.12e-05	0.000694	CcSEcCtD
Bezafibrate—Headache—Irbesartan—type 2 diabetes mellitus	3.1e-05	0.00069	CcSEcCtD
Bezafibrate—Dizziness—Losartan—type 2 diabetes mellitus	3.08e-05	0.000686	CcSEcCtD
Bezafibrate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000655	CcSEcCtD
Bezafibrate—Nausea—Irbesartan—type 2 diabetes mellitus	2.94e-05	0.000655	CcSEcCtD
Bezafibrate—Rash—Losartan—type 2 diabetes mellitus	2.94e-05	0.000654	CcSEcCtD
Bezafibrate—Dermatitis—Losartan—type 2 diabetes mellitus	2.93e-05	0.000653	CcSEcCtD
Bezafibrate—Headache—Losartan—type 2 diabetes mellitus	2.92e-05	0.00065	CcSEcCtD
Bezafibrate—Pruritus—Ramipril—type 2 diabetes mellitus	2.83e-05	0.000629	CcSEcCtD
Bezafibrate—Nausea—Losartan—type 2 diabetes mellitus	2.77e-05	0.000616	CcSEcCtD
Bezafibrate—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.73e-05	0.000609	CcSEcCtD
Bezafibrate—Dizziness—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000588	CcSEcCtD
Bezafibrate—Rash—Ramipril—type 2 diabetes mellitus	2.52e-05	0.000561	CcSEcCtD
Bezafibrate—Dermatitis—Ramipril—type 2 diabetes mellitus	2.52e-05	0.00056	CcSEcCtD
Bezafibrate—Headache—Ramipril—type 2 diabetes mellitus	2.5e-05	0.000557	CcSEcCtD
Bezafibrate—Nausea—Ramipril—type 2 diabetes mellitus	2.37e-05	0.000528	CcSEcCtD
Bezafibrate—Indomethacin—PTGS2—type 2 diabetes mellitus	2.04e-05	0.0132	CrCbGaD
Bezafibrate—Glyburide—CYP3A4—type 2 diabetes mellitus	1.88e-05	0.0122	CrCbGaD
Bezafibrate—Indomethacin—ALB—type 2 diabetes mellitus	1.82e-05	0.0117	CrCbGaD
Bezafibrate—Glyburide—ALB—type 2 diabetes mellitus	1.64e-05	0.0106	CrCbGaD
Bezafibrate—CYP2C8—Metabolism—HK1—type 2 diabetes mellitus	2.21e-06	5.43e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.21e-06	5.42e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	2.2e-06	5.42e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	2.2e-06	5.42e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—NOS3—type 2 diabetes mellitus	2.19e-06	5.38e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3R1—type 2 diabetes mellitus	2.19e-06	5.38e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CD36—type 2 diabetes mellitus	2.17e-06	5.34e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.17e-06	5.32e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PPP2CA—type 2 diabetes mellitus	2.14e-06	5.27e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—LPA—type 2 diabetes mellitus	2.13e-06	5.24e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HSD3B2—type 2 diabetes mellitus	2.13e-06	5.24e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—KCNJ11—type 2 diabetes mellitus	2.13e-06	5.24e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GCKR—type 2 diabetes mellitus	2.13e-06	5.24e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.12e-06	5.22e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.1e-06	5.16e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ALB—type 2 diabetes mellitus	2.09e-06	5.14e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	2.09e-06	5.13e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	2.09e-06	5.13e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GLP1R—type 2 diabetes mellitus	2.07e-06	5.1e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—MTHFR—type 2 diabetes mellitus	2.06e-06	5.06e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.05e-06	5.04e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALDOB—type 2 diabetes mellitus	2.04e-06	5.02e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PPARA—type 2 diabetes mellitus	2.02e-06	4.96e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3R1—type 2 diabetes mellitus	2e-06	4.92e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—NOS3—type 2 diabetes mellitus	2e-06	4.92e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTGS2—type 2 diabetes mellitus	2e-06	4.92e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.99e-06	4.9e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.99e-06	4.88e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.98e-06	4.86e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GNB3—type 2 diabetes mellitus	1.98e-06	4.86e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—HMOX1—type 2 diabetes mellitus	1.97e-06	4.83e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AGT—type 2 diabetes mellitus	1.96e-06	4.8e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.95e-06	4.78e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CAT—type 2 diabetes mellitus	1.94e-06	4.77e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.94e-06	4.76e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.93e-06	4.75e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.92e-06	4.73e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CALM1—type 2 diabetes mellitus	1.92e-06	4.72e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APOE—type 2 diabetes mellitus	1.92e-06	4.71e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GLP1R—type 2 diabetes mellitus	1.9e-06	4.67e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MTR—type 2 diabetes mellitus	1.9e-06	4.66e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CPT1A—type 2 diabetes mellitus	1.9e-06	4.66e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APOA1—type 2 diabetes mellitus	1.89e-06	4.65e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOB—type 2 diabetes mellitus	1.88e-06	4.63e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NAMPT—type 2 diabetes mellitus	1.86e-06	4.57e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.85e-06	4.54e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HBA1—type 2 diabetes mellitus	1.85e-06	4.54e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GCK—type 2 diabetes mellitus	1.85e-06	4.54e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—LIPC—type 2 diabetes mellitus	1.85e-06	4.54e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.84e-06	4.52e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.84e-06	4.52e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.84e-06	4.51e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTM1—type 2 diabetes mellitus	1.83e-06	4.5e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTGS2—type 2 diabetes mellitus	1.83e-06	4.5e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.8e-06	4.43e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—LPL—type 2 diabetes mellitus	1.8e-06	4.42e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6—type 2 diabetes mellitus	1.8e-06	4.42e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CETP—type 2 diabetes mellitus	1.78e-06	4.38e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.78e-06	4.37e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.78e-06	4.37e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.78e-06	4.37e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.78e-06	4.37e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.78e-06	4.37e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	1.77e-06	4.36e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ADCY5—type 2 diabetes mellitus	1.76e-06	4.33e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GPX1—type 2 diabetes mellitus	1.76e-06	4.31e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	1.74e-06	4.27e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	1.74e-06	4.27e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.72e-06	4.23e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CD36—type 2 diabetes mellitus	1.71e-06	4.2e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	1.71e-06	4.19e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.7e-06	4.17e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	1.69e-06	4.16e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	1.69e-06	4.16e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	1.69e-06	4.16e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.69e-06	4.15e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	1.68e-06	4.14e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.66e-06	4.09e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—type 2 diabetes mellitus	1.66e-06	4.08e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PSMD6—type 2 diabetes mellitus	1.66e-06	4.07e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SREBF1—type 2 diabetes mellitus	1.66e-06	4.07e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SNAP25—type 2 diabetes mellitus	1.66e-06	4.07e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	1.65e-06	4.06e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—INS—type 2 diabetes mellitus	1.64e-06	4.02e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	1.63e-06	4.02e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CTGF—type 2 diabetes mellitus	1.63e-06	4e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.62e-06	3.99e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.62e-06	3.99e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—MTHFR—type 2 diabetes mellitus	1.62e-06	3.98e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HMGCR—type 2 diabetes mellitus	1.61e-06	3.96e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.59e-06	3.91e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARA—type 2 diabetes mellitus	1.59e-06	3.91e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.58e-06	3.89e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.58e-06	3.88e-05	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—type 2 diabetes mellitus	1.55e-06	3.82e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AGT—type 2 diabetes mellitus	1.54e-06	3.78e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.52e-06	3.75e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	1.52e-06	3.73e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	1.52e-06	3.73e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	1.52e-06	3.73e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.52e-06	3.73e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CALM1—type 2 diabetes mellitus	1.51e-06	3.72e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.51e-06	3.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.51e-06	3.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.51e-06	3.71e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOE—type 2 diabetes mellitus	1.51e-06	3.71e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ALB—type 2 diabetes mellitus	1.5e-06	3.69e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.5e-06	3.68e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.5e-06	3.68e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	1.49e-06	3.67e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOA1—type 2 diabetes mellitus	1.49e-06	3.66e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	1.48e-06	3.63e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.46e-06	3.59e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.46e-06	3.58e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.45e-06	3.57e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.45e-06	3.56e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.45e-06	3.56e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	1.45e-06	3.55e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GCG—type 2 diabetes mellitus	1.44e-06	3.53e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.44e-06	3.53e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3R1—type 2 diabetes mellitus	1.44e-06	3.53e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—NOS3—type 2 diabetes mellitus	1.44e-06	3.53e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.39e-06	3.43e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.39e-06	3.43e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	1.39e-06	3.42e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	1.37e-06	3.38e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	1.37e-06	3.38e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.37e-06	3.37e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.35e-06	3.31e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.35e-06	3.31e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.35e-06	3.31e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	1.34e-06	3.29e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.33e-06	3.28e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	1.32e-06	3.24e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	1.32e-06	3.24e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	1.31e-06	3.23e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS2—type 2 diabetes mellitus	1.31e-06	3.22e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	1.29e-06	3.17e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.27e-06	3.11e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.24e-06	3.04e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	1.24e-06	3.04e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	1.23e-06	3.03e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	1.22e-06	2.99e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—type 2 diabetes mellitus	1.21e-06	2.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.19e-06	2.91e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—type 2 diabetes mellitus	1.18e-06	2.91e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	1.18e-06	2.9e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	1.18e-06	2.9e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	1.15e-06	2.82e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.14e-06	2.81e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.14e-06	2.81e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.14e-06	2.81e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.14e-06	2.81e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	1.14e-06	2.79e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.14e-06	2.79e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	1.13e-06	2.78e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.13e-06	2.78e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	1.13e-06	2.78e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	1.13e-06	2.77e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	1.12e-06	2.74e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	1.1e-06	2.71e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	1.1e-06	2.7e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.1e-06	2.7e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	1.08e-06	2.66e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	1.07e-06	2.63e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.06e-06	2.6e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	1.05e-06	2.59e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	1.03e-06	2.54e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	1.03e-06	2.54e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.02e-06	2.51e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.02e-06	2.5e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	1.01e-06	2.49e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	1.01e-06	2.48e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	2.47e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	9.96e-07	2.45e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	9.83e-07	2.41e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	9.7e-07	2.38e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	9.65e-07	2.37e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	9.53e-07	2.34e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	9.49e-07	2.33e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	9.45e-07	2.32e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	9.35e-07	2.3e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	9.33e-07	2.29e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	9.33e-07	2.29e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	9.31e-07	2.29e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—type 2 diabetes mellitus	9.2e-07	2.26e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	9.15e-07	2.25e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	9.13e-07	2.24e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	9.1e-07	2.23e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	9.1e-07	2.23e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	9.1e-07	2.23e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	9.04e-07	2.22e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	8.88e-07	2.18e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	8.85e-07	2.17e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	8.77e-07	2.16e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	8.7e-07	2.14e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	8.67e-07	2.13e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	8.57e-07	2.11e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—type 2 diabetes mellitus	8.48e-07	2.08e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	8.23e-07	2.02e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	8.16e-07	2e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	8.16e-07	2e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	8.16e-07	2e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	8.08e-07	1.98e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	8.01e-07	1.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	7.94e-07	1.95e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	7.77e-07	1.91e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	7.55e-07	1.85e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	7.46e-07	1.83e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	7.4e-07	1.82e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	7.4e-07	1.82e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	7.38e-07	1.81e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	7.38e-07	1.81e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	7.08e-07	1.74e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.08e-07	1.74e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	7.07e-07	1.74e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	7.07e-07	1.74e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	6.79e-07	1.67e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—type 2 diabetes mellitus	6.6e-07	1.62e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	6.49e-07	1.6e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	6.49e-07	1.6e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	6.48e-07	1.59e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	6.1e-07	1.5e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.1e-07	1.5e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	6.07e-07	1.49e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.99e-07	1.47e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	5.94e-07	1.46e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.81e-07	1.43e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.65e-07	1.39e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.55e-07	1.36e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.43e-07	1.34e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.41e-07	1.33e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	5.27e-07	1.3e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	5.21e-07	1.28e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	5.19e-07	1.28e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	5e-07	1.23e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.9e-07	1.2e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.75e-07	1.17e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.67e-07	1.15e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.65e-07	1.14e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.6e-07	1.13e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	4.05e-07	9.96e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.97e-07	9.77e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.64e-07	8.95e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.49e-07	8.56e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.49e-07	8.56e-06	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	3.26e-07	8e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.19e-07	7.83e-06	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	2.98e-07	7.33e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.6e-07	3.94e-06	CbGpPWpGaD
